Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Anagenics ( (AU:AN1) ) is now available.
Anagenics Limited reported its quarterly cash flow, indicating a net cash outflow from operating activities of $424,000 for the current quarter and $1,708,000 year-to-date. Despite the operational cash outflow, the company secured $450,000 from borrowings, resulting in a net cash inflow of $321,000 from financing activities for the quarter. This financial maneuvering highlights Anagenics’ efforts to stabilize its cash position amidst ongoing operational expenses, which could impact its strategic initiatives and stakeholder confidence.
More about Anagenics
Anagenics Limited operates in the biotechnology industry, focusing on developing and commercializing innovative health and beauty products. The company is dedicated to advancing its product offerings to cater to market demands, primarily targeting consumer health and wellness sectors.
Current Market Cap: A$3.69M
Find detailed analytics on AN1 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue